519 related articles for article (PubMed ID: 32696341)
1. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
Ferini-Strambi L; Salsone M
J Neurol; 2021 Feb; 268(2):409-419. PubMed ID: 32696341
[TBL] [Abstract][Full Text] [Related]
2. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?
Verkhratsky A; Li Q; Melino S; Melino G; Shi Y
Biol Direct; 2020 Nov; 15(1):28. PubMed ID: 33246479
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Mortality Risk of Neurological Disorders during the COVID-19 Pandemic: An Umbrella Review of the Current Evidence.
Park JM; Woo W; Lee SC; Park S; Yon DK; Lee SW; Smith L; Koyanagi A; Shin JI; Kim YW
Neuroepidemiology; 2023; 57(3):129-147. PubMed ID: 37044073
[TBL] [Abstract][Full Text] [Related]
4. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease.
Zhang J
Front Neurol; 2022; 13():968193. PubMed ID: 36570463
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?
McAlpine LS; Fesharaki-Zadeh A; Spudich S
Curr Opin Psychiatry; 2021 Mar; 34(2):177-185. PubMed ID: 33395100
[TBL] [Abstract][Full Text] [Related]
6. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?
Krey L; Huber MK; Höglinger GU; Wegner F
Brain Sci; 2021 Dec; 11(12):. PubMed ID: 34942956
[TBL] [Abstract][Full Text] [Related]
7. Bridging the gap: large animal models in neurodegenerative research.
Eaton SL; Wishart TM
Mamm Genome; 2017 Aug; 28(7-8):324-337. PubMed ID: 28378063
[TBL] [Abstract][Full Text] [Related]
8. [COVID-19 as a trigger for the onset and progression of neurodegenerative pathology predominantly in elderly and senile population.].
Ariev AL; Lapteva ES
Adv Gerontol; 2023; 36(6):810-817. PubMed ID: 38426917
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection as a cause of neurodegeneration.
Bonhenry D; Charnley M; Gonçalves J; Hammarström P; Heneka MT; Itzhaki R; Lambert JC; Mannan M; Baig AM; Middeldorp J; Nyström S; Reynolds NP; Stefanatou M; Berryman JT
Lancet Neurol; 2024 Jun; 23(6):562-563. PubMed ID: 38760096
[No Abstract] [Full Text] [Related]
10. Prevalence, pathogenesis and spectrum of neurological symptoms in COVID-19 and post-COVID-19 syndrome.
Finsterer J; Scorza FA
Med J Aust; 2024 Apr; 220(6):341. PubMed ID: 38396384
[No Abstract] [Full Text] [Related]
11. Low-Dose Radiation Therapy for Neurological Disorders: A Double-Edged Sword.
Weerasinghe-Mudiyanselage PDE; Kim JS; Kang S; Lee YS; Son Y; Lee HJ; Moon C
Discov Med; 2024 May; 36(184):898-912. PubMed ID: 38798250
[TBL] [Abstract][Full Text] [Related]
12. Acute and late neurological complications of COVID19: the quest for evidence.
Xiong W; Kwan P; Zhou D; Del Felice A; Duncan JS; Sander JW
Brain; 2020 Dec; 143(12):e99. PubMed ID: 32995833
[No Abstract] [Full Text] [Related]
13. The cognitive consequences of the COVID-19 epidemic: collateral damage?
Ritchie K; Chan D; Watermeyer T
Brain Commun; 2020; 2(2):fcaa069. PubMed ID: 33074266
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection.
Iacono S; Schirò G; Davì C; Mastrilli S; Abbott M; Guajana F; Arnao V; Aridon P; Ragonese P; Gagliardo C; Colomba C; Scichilone N; D'Amelio M
Front Neurol; 2023; 14():1172416. PubMed ID: 37273689
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and the impact on Alzheimer's disease pathology.
Furman S; Green K; Lane TE
J Neurochem; 2023 Oct; ():. PubMed ID: 37850241
[TBL] [Abstract][Full Text] [Related]
16. Don't miss the diagnosis: neurological manifestations as presenting features of COVID-19.
Madan A; Agarwal P; Ray S; Tyson B
Clin Med (Lond); 2023 Nov; 23(Suppl 6):7. PubMed ID: 38182227
[No Abstract] [Full Text] [Related]
17. Severe COVID-19 Linked to Enduring Immune System Changes.
Harris E
JAMA; 2023 Sep; 330(11):1030. PubMed ID: 37647097
[No Abstract] [Full Text] [Related]
18. The Future of COVID-19 for Patients With Immune-Mediated Inflammatory Diseases: Who Is at Risk?
Calabrese C
J Rheumatol; 2024 Mar; 51(3):221-223. PubMed ID: 38224980
[No Abstract] [Full Text] [Related]
19. COVID-19: dealing with a potential risk factor for chronic neurological disorders.
Schirinzi T; Landi D; Liguori C
J Neurol; 2021 Apr; 268(4):1171-1178. PubMed ID: 32852580
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.
Sulzer D; Antonini A; Leta V; Nordvig A; Smeyne RJ; Goldman JE; Al-Dalahmah O; Zecca L; Sette A; Bubacco L; Meucci O; Moro E; Harms AS; Xu Y; Fahn S; Ray Chaudhuri K
NPJ Parkinsons Dis; 2020; 6():18. PubMed ID: 32885037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
